Heterotopic ossification induced by Achilles tenotomy via endochondral bone formation: Expression of bone and cartilage related genes

Bone

Volumn 46, Issue 2, 2010, Pages 425-431

  Lin, Lin ^a   Shen, Qi ^b   Xue, Tao ^a   Yu, Changlong ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Achilles tenotomy; Chondrogenesis; Endochondral ossification; Heterotopic ossification; HIF 1

Indexed keywords

AGGRECAN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; OSTEOGENIC PROTEIN 1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN;

ACHILLES TENDON; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CHONDROGENESIS; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; GENE EXPRESSION REGULATION; HETEROTOPIC OSSIFICATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR MECHANICS; NONHUMAN; POSTOPERATIVE PERIOD; RAT; REAL TIME POLYMERASE CHAIN REACTION; SURGICAL APPROACH; TENOTOMY; UPREGULATION; X RAY ANALYSIS;

ACHILLES TENDON; ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE MATRIX; CARTILAGE; CHONDROGENESIS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SPECIFICITY; OSSIFICATION, HETEROTOPIC; OSTEOGENESIS; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 74249110557     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.08.057     Document Type: Article

References (35)

1. Pape H.C., Marsh S., Morley J.R., Krettek C., and Giannoudis P.V. Current concepts in the development of heterotopic ossification. J. Bone Joint Surg. Br. 86 (2004) 783-787
2. Grimaud E., Heymann D., and Redini F. Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor. Rev. 13 (2002) 241-257
3. Toom A., Arend A., Gunnarsson D., Ulfsparre R., Suutre S., Haviko T., et al. Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3. Calcif. Tissue Int. 80 (2007) 259-267
4. Robey P.G., Young M.F., Flanders K.C., Roche N.S., Kondaiah P., Reddi A.H., et al. Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J. Cell. Biol. 105 (1987) 457-463
5. Horner A., Kemp P., Summers C., Bord S., Bishop N.J., Kelsall A.W., et al. Expression and distribution of transforming growth factor-beta iso-forms and their signaling receptors in growing human bone. Bone 23 (1998) 95-102
6. Sawyer J.R., Myers M.A., Rosier R.N., and Puzas J.E. Heterotopic ossification: clinical and cellular aspects. Calcif. Tissue Int. 49 (1991) 208-215
7. Suutre S., Toom A., Arend A., and Selstam G. Bone tissue content of TGF-beta (2) changes with time in human heterotopic ossification after total hip arthroplasty. Growth Factors 27 (2009) 114-120
8. Roark E.F., and Greer K. Transforming growth factorbeta and bone morphogenetic protein-2 act by distinct mechanisms to promote chick limb cartilage differentiation in vitro. Dev. Dyn. 200 (1994) 103-116
9. Yoon B.S., and Lyons K.M. Multiple functions of BMPs in chondrogenesis. J. Cell. Biochem. 93 (2004) 93-103
10. Hayashi K., Ishidou Y., Yonemori K., Nagamine T., Origuchi N., Maeda S., et al. Expression and localization of bone morphogenetic proteins (BMPs) and BMP receptors in ossification of the ligamentum flavum. Bone 21 (1997) 23-30
11. Bridgewater L.C., Walker M.D., Miller G.C., Ellison T.A., Holsinger L.D., Potter J.L., et al. Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements. Nucleic Acids Res. 31 (2003) 1541-1553
12. Lefebvre V., Li P., and de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17 (1998) 5718-5733
13. Robins J.C., Akeno N., Mukherjee A., Dalal R.R., Aronow B.J., Koopman P., et al. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 37 (2005) 313-322
14. Gersbach C.A., Byers B.A., Pavlath G.K., and Garcia A.J. Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp. Cell. Res. 300 (2004) 406-417
15. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771
16. Michelsson J.E., Granroth G., and Andersson L.C. Myositis ossificans following forcible manipulation of the leg. A rabbit model for the study of heterotopic bone formation. J. Bone Joint Surg. Am. 62 (1980) 811-815
17. Rumi M.N., Deol G.S., Singapuri K.P., and Pellegrini Jr. V.D. The origin of osteoprogenitor cells responsible for heterotopic ossification following hip surgery: an animal model in the rabbit. J. Orthop. Res. 23 (2005) 34-40
18. Lin L., Chen L., Wang H., Wei X., Fu X., Zhang J., et al. Adenovirus-mediated transfer of siRNA against Runx2/Cbfa1 inhibits the formation of heterotopic ossification in animal model. Biochem. Biophys. Res. Commun. 349 (2006) 564-572
19. O'Connor J.P. Animal models of heterotopic ossification. Clin. Orthop. Relat. Res. 346 (1998) 71-80
20. Buck R.C. Regeneration of tendon. J. Pathol. Bacteriol. 66 (1953) 1-18
21. McClure J. The effect of diphosphonates on heterotopic ossification in regenerating Achilles tendon of the mouse. J. Pathol 139 (1983) 419-430
22. Byers B.A., Pavlath G.K., Murphy T.J., Karsenty G., and Garcia A.J. Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfal. J. Bone Miner. Res. 17 11 (2002) 1931-1944
23. Hannallah D., Peng H., Young B., Usas A., Gearhart B., and Huard J. Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J. Bone Joint Surg. Am. 86 (2004) 80-91
24. Metzen E., Wolff M., Fandrey J., and Jelkmann W. Pericellular PO2 and O2 consumption in monolayer cell cultures. Respir. Physiol. 100 (1995) 101-106
25. Lee J.W., Bae S.H., Jeong J.W., Kim S.H., and Kim K.W. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp. Mol. Med. 36 (2004) 1-12
26. Schipani E., Ryan H.E., Didrickson S., Kobayashi T., Knight M., and Johnson R.S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 15 (2001) 2865-2876
27. Yaoita H., Orimo H., Shirai Y., and Shimada T. Expression of bone morphogenetic proteins and rat distal-less homolog genes following rat femoral fracture. J. Bone Miner. Metab. 18 (2000) 63-70
28. Kloen P., Di Paola M., Borens O., Richmond J., Perino G., Helfet D.L., et al. BMP signaling components are expressed in human fracture callus. Bone 33 (2003) 362-371
29. Simon T.M., Van Sickle D.C., Kunishima D.H., and Jackson D.W. Cambium cell stimulation from surgical release of the periosteum. J. Orthop. Res. 21 (2003) 470-480
30. Yoon B.S., Pogue R., Ovchinnikov D.A., Yoshii I., Mishina Y., Behringer R.R., et al. BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development 133 (2006) 4667-4668
31. Emans P.J., Spaapen F., Surtel D.A., Reilly K.M., Cremers A., van Rhijn L.W., et al. A novel in vivo model to study endochondral bone formation; HIF-1alpha activation and BMP expression. Bone 40 2 (2007) 409-418
32. Koritzinsky M., Magagnin M.G., van den Beucken T., Seigneuric R., Savelkouls K., Dostie J., et al. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO 25 (2006) 1114-1125
33. Maeda S., Hayashi M., Komiya S., Imamura T., and Miyazono K. Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J. 23 (2004) 552-563
34. Ducy P., Zhang R., Geoffroy V., Ridall A., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
35. Shui C., and Scutt A.M. Mouse embryo-derived NIH3T3 fibroblasts adopt an osteoblast-like phenotype when treated with 1alpha, 25-dihydroxyvitamin D (3) and dexamethasone in vitro. J. Cell. Physiol. 193 2 (2002) 164-172